NCT06797362
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06797362 |
| Title | Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC (NVL-520-EAP) |
| Acronym | NVL-520-EAP |
| Recruitment | Available |
| Gender | both |
| Phase | Expanded access |
| Variant Requirements | Yes |
| Sponsors | Nuvalent Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | NLD | ITA | GBR | FRA | ESP | CAN | AUS |
CKB BOOST